Angehefteter Tweet
So grateful for this amazing team of patients, advocates and colleagues who work every day to improve the lives of patients diagnosed with IBC! Team IBC at Jimmy Fund Walk 2023 @IBC_DanaFarber @DFCI_BreastOnc @TalkIBC
English
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸
666 posts
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸
@FilipaLynce
Breast Oncologist @ Dana-Farber Cancer Institute. Director, Dana Farber IBC Program. DFCI Center for BRCA and related genes. Alliance EO. Tweets are my own.
Boston, MA Beigetreten Kasım 2014
541 Folgt1.7K Follower
Singer and salon owner Shirley Joseph (@ShellzWithAZ) was only 33 when she was diagnosed with #InflammatoryBreastCancer. The news put much of her career on hold, but fortunately she was able to lean on her husband Mike Joseph for support. Learn more about their journey and how @DanaFarber's Leticia Varella, MD, (@VarellaLeticia1) and the #IBC Program, supported this young couple. #BreastCancer
youtube.com/watch?v=6Oui4n…
YouTube
English
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweetet
We are leading a phase 2 study, called #TRUDI, to test the safety and effectiveness of an investigational drug combination (trastuzumab deruxtecan and #durvalumab) to learn if the intervention works in stage III, HER2-expressing #InflammatoryBreastCancer.
👉dana-farber.org/clinical-trial…
PI: @FilipaLynce #TDXd #BreastCancer #IBC @IBC_DanaFarber
English
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweetet
Dr. Illana Schlam @IlanaSchlam will share the latest research in applying ctDNA to treat early breast cancer and how that may apply to IBC. Register for our April 11 at our IBC Patient Forum redcap.link/IBCPatientFour….
English
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweetet
Join us On April 11! Dr. Faina Nakhlis will talk about what happens in the OR, including Axillary Lymph Node Dissection, Modified Radical Mastectomy and Delayed Reconstruction as Standards of Care for IBC. Register Here: redcap.link/IBCPatientFour…
English
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweetet
Congratulations to Catherine Wu, MD, on being recognized by @TIME in the TIME100 Health 2026 list. Read more: bit.ly/4kEx3ru
English
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweetet
On April 11, Dr. Paolo Tarantino @PTarantinoMD will share with us the latest research in utilizing antibody drug conjugates in breast cancer and what that may mean for IBC. Register for the IBC Patient Forum TODAY: redcap.link/IBCPatientFour…
English
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweetet
New #IBC Publication 👉Assessing the accuracy of #InflammatoryBreastCancer self-reported diagnoses through the #MetastaticBreastCancer project from the count me in initiative database.
pubmed.ncbi.nlm.nih.gov/41441993/
✍️@PietroDePlacido @IBCnurse @aditihazra @Nikhilwagle @mcgillimary @nlinmd @stolaney1 @FilipaLynce #BreastCancer #MBC @IBC_DanaFarber
English
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweetet
Don't miss this recent @ESMO_Open paper on pathological complete response with neoadjuvant #pembrolizumab and chemotherapy in non-metastatic triple negative #InflammatoryBreastCancer
sciencedirect.com/science/articl…
@FilipaLynce @KristinaFanucci @antgiorda @jenniferbellon2 @lwarrenMD @CBlockMD @thomas_bachelot @BarbaraPistill2 @DrLisaCarey @stolaney1 @IBCradiation @IBC_DanaFarber #IBC
English
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweetet
Join us on Saturday, April 11, at 10 am, for the 8th Annual #InflammatoryBreastCancer Patient Forum. This free virtual forum will provide information about #IBC for patients, their friends and loved ones, and healthcare professionals. All are welcome!
👉redcap.partners.org/redcap/surveys… @IBC_DanaFarber @IBCResearch @TalkIBC #BreastCancer @FilipaLynce
English
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweetet
So nice to have @AnaBaracCardio at @DFCI_BreastOnc this morning - great to catch up over coffee ☕️@FilipaLynce
English
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweetet
Meet Dr. Charlotte Walmsley, a new Advanced Fellow in the Breast Oncology Center @DanaFarber. Originally from Massachusetts, Dr. Walmsley earned her MD at @BIDMChealth. Her research focuses on #BRCA associated #BreastCancers and mechanisms of cancer resistance. Welcome, Dr. Walmsley!
English
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweetet
New publication 👉A phase Ib study of #sapacitabine and #olaparib in patients with BRCA1/2-mutated #MetastaticBreastCancer.
pubmed.ncbi.nlm.nih.gov/41335237/
@FilipaLynce @DrBBychkovsky @PhilipPoorvu @NabihahTayob @GShapiroMDPhD @stolaney1
English
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweetet
We are leading a phase 2 study, called #TRUDI, to test the safety and effectiveness of an investigational drug combination (trastuzumab deruxtecan and durvalumab) to learn if the intervention works in stage III, HER2-expressing #InflammatoryBreastCancer.
dana-farber.org/clinical-trial…
PI: @FilipaLynce #TDXd #BreastCancer #IBC @IBC_DanaFarber
English
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweetet
Path CR with NACT + pembrolizumab (K522reg) in non-metastatic TNBC #inflammatory breast cancer set at 31.7%. Need for better patient selection and more active treatment options for this rare and aggressive breast cancer subtype. #bcsm @FilipaLynce esmoopen.com/article/S2059-…
English
@EMittendorfMD @stolaney1 What an outstanding talk! Congratulations to a transformational and generous doctor, mentor and leader. We are very fortunate to have you as our leader! @DFCI_BreastOnc
English
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweetet
Adela Rodríguez-Hernández (@AdelaRodrguezH1) with @DanaFarber mentors, Judy Garber (@judygarber5) and Filipa Lynce (@FilipaLynce), at the #SABCS25 poster session showcasing their research on the impact of #BRCA homozygous copy loss on clinical outcomes of patients with #MetastaticBreastCancer (#MBC) treated with #PARP inhibitors.
English
Congratulations to friend and colleague @stolaney1 for her well deserved recognition with the AACR outstanding Investigator Award for her work to advance our efforts personalizing therapy for breast cancer patients.
Dana-Farber’s Breast Oncology Center@DFCI_BreastOnc
Sara Tolaney, MD, MPH (@stolaney1) delivering the #SABCS25 Outstanding Investigator Award for Breast Cancer Research. Dr. Tolaney's leadership in establishing biomarker-driven personalized therapy approaches for cancer, including the development of CDK4/6 inhibitors, has significantly advanced care in both metastatic and adjuvant settings, shaping the future of precision oncology for patients with #BreastCancer. @AACR @BCRFcure
English
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweetet
Another #sabcs25 in the books. Such a team effort from all our committees staff volunteers advocates. Thank you to my codirector @CarlosArteagaMD and the Sabcs program coordinator @KateIdaLathrop. See you all next year. @SABCSSanAntonio @mayscancer @AACR
English
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweetet
Thanks @matteolambe for making the way to DFCI to give a wonderful lecture and review all the terrific work you’ve been conducting in the field of breast cancer in young patients over the last decade. Such a great inspiration for us all (and pride for Italian oncs! 🇮🇹)
English
Filipa Lynce, MD, FASCO 🇵🇹 🇺🇸 retweetet
This will be a fantastic discussion of #ESMO25 breast cancer news, and there was a lot!
Registration for the live webinar is free, but required.
Link here:
dfci.zoom.us/webinar/regist…
Dana-Farber’s Breast Oncology Center@DFCI_BreastOnc
What are the most important takeaways from #ESMO25 for #BreastCancer care? Join @DanaFarber experts on Nov 14th for our live #BreastCancerBreakthroughs webinar discussing the latest clinical advances, research highlights, and their impact on patient care. 📅November 14, 1:30–2:30 PM EST 👉Register for free today: bit.ly/3WvQUhi Moderator: @DrHBurstein Panelists: @stolaney1 @nlinmd @FilipaLynce #AnaGarridoCastro
English